| Sjogren's syndrome: An update on disease pathogenesis, clinical manifestations and treatment |
25 |
| Role of the JAK/STAT signaling pathway in regulation of innate immunity in neuroinflammatory diseases |
21 |
| Type I interferon pathway activation in COPA syndrome |
18 |
| Hydroxychloroquine efficiently suppresses inflammatory responses of human class-switched memory B cells via Toll-like receptor 9 inhibition |
17 |
| Subcutaneous immunoglobulins in patients with multiple myeloma and secondary hypogammaglobulinemia: a randomized trial |
15 |
| Epigenetic interplay between immune, stromal and cancer cells in the tumor microenvironment |
15 |
| HLA-G protein expression in colorectal cancer evaluated by immunohistochemistry and western blot analysis: Its expression characteristics remain enigmatic |
13 |
| Non-progressing cancer patients have persistent B cell responses expressing shared antibody paratopes that target public tumor antigens |
13 |
| Safety profile after prolonged C3 inhibition |
13 |
| Autoimmune/inflammatory syndrome induced by adjuvants (ASIA) demonstrates distinct autoimmune and autoinflammatory disease associations according to the adjuvant subtype: Insights from an analysis of 500 cases |
13 |
| The contribution of neutrophils to CNS autoimmunity |
12 |
| The hyper IgM syndromes: Epidemiology, pathogenesis, clinical manifestations, diagnosis and management |
11 |
| The contribution of macrophages to systemic lupus erythematosus |
11 |
| Th17 and Treg lymphocytes in obesity and Type 2 diabetic patients |
11 |
| CD8(+) T cells expressing both PD-1 and TIGIT but not CD226 are dysfunctional in acute myeloid leukemia (AML) patients |
11 |
| An emerging role for eotaxins in neurodegenerative disease |
11 |
| Biological therapies in inflammatory bowel disease: Beyond anti-TNF therapies |
10 |
| Cytokines, growth factors and proteases in medium and large vessel vasculitis |
10 |
| Cisplatin inhibits the progression of bladder cancer by selectively depleting G-MDSCs: A novel chemoimmunomodulating strategy |
10 |
| Gain-of-function variants in NLRP1 protect against the development of diabetic kidney disease: NLRP1 inflammasome role in metabolic stress sensing? |
9 |
| Microbial transglutaminase: A new potential player in celiac disease |
9 |
| Circulating IL-17-producing mucosal-associated invariant T cells (MAIT) are associated with symptoms in children with asthma |
9 |
| The inhibition of 5-Lipoxygenase (5-LO) products leukotriene B4 (LTB4) and cysteinyl leukotrienes (cysLTs) modulates the inflammatory response and improves cutaneous wound healing |
9 |
| Efficacy of anti-TNF alpha in severe and refractory major vessel involvement of Behcet's disease: A multicenter observational study of 18 patients |
9 |
| Extracellular ATP signaling and clinical relevance |
9 |
| Immature myeloid cells in the tumor microenvironment: Implications for immunotherapy |
8 |
| Targeting cytokines to treat autoinflammatory diseases |
8 |
| NLRP3 inflammasome regulates Th17 differentiation in rheumatoid arthritis |
8 |
| Immunogenicity to cerliponase alfa intracerebroventricular enzyme replacement therapy for CLN2 disease: Results from a Phase 1/2 study |
8 |
| B cell phenotypes, signaling and their roles in secretion of antibodies in systemic lupus erythematosus |
8 |
| Characterization of Vibrio cholerae neuraminidase as an immunomodulator for novel formulation of oral allergy immunotherapy |
8 |
| Clinical and economic aspects of newborn screening for severe combined immunodeficiency: DEPISTREC study results |
8 |
| 2B4 and CD48: A powerful couple of the immune system |
8 |
| Effect of high glucose on cytokine production by human peripheral blood immune cells and type I interferon signaling in monocytes: Implications for the role of hyperglycemia in the diabetes inflammatory process and host defense against infection |
8 |
| Residual T cell activation and skewed CD8+T cell memory differentiation despite antiretroviral therapy-induced HIV suppression |
8 |
| Potential therapeutic applications of exosomes in different autoimmune diseases |
8 |
| Immune aging in diabetes and its implications in wound healing |
7 |
| The long-term prognostic significance of sarcoidosis-associated pulmonary hypertension A cohort study |
7 |
| Heparin and aspirin combination therapy restores T-cell phenotype in pregnant patients with antiphospholipid syndrome-related recurrent pregnancy loss |
7 |
| Diminished antibody response to influenza vaccination is characterized by expansion of an age-associated B-cell population with low PAX5 |
7 |
| The exosome as a novel predictive/diagnostic biomarker of rejection in the field of transplantation |
7 |
| Epigenetics as biomarkers in autoimmune diseases |
7 |
| The inhibitory receptors on NK cells and CTLs are upregulated in adult and adolescent patients with secondary hemophagocytic lymphohistiocytosis |
7 |
| Genetic and inflammatory factors associated with psoriatic arthritis: Relevance to diagnosis and management |
7 |
| Increase of follicular helper T cells skewed toward a Th1 profile in CVID patients with non-infectious clinical complications |
7 |
| Cytokine targets in lupus nephritis: Current and future prospects |
6 |
| Pediatric-onset Evans syndrome: Heterogeneous presentation and high frequency of monogenic disorders including LRBA and CTLA4 mutations |
6 |
| The novel cytokine Metrnl/IL-41 is elevated in Psoriatic Arthritis synovium and inducible from both entheseal and synovial fibroblasts |
6 |
| B cells and their cytokine activities implications in human diseases |
6 |
| Treatment of murine lupus with TIGIT-Ig |
6 |
